scispace - formally typeset
A

Alexander S. Korb

Researcher at University of California, Los Angeles

Publications -  22
Citations -  786

Alexander S. Korb is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Neuromodulation (medicine) & Anterior cingulate cortex. The author has an hindex of 12, co-authored 21 publications receiving 616 citations. Previous affiliations of Alexander S. Korb include Semel Institute for Neuroscience and Human Behavior.

Papers
More filters
Journal ArticleDOI

Non-Invasive Ultrasonic Thalamic Stimulation in Disorders of Consciousness after Severe Brain Injury: A First-in-Man Report

TL;DR: A large number of patients fail to fully recover from coma, and awaken to a disorder of consciousness such as the vegetative state or the minimally conscious state, which can be transient or last indefinitely.
Journal ArticleDOI

Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression.

TL;DR: Results support the potential clinical utility of this approach for predicting clinical outcome to antidepressant treatments in MDD and suggest theta current density in the rACC and mOFC may be useful as a biomarker for prediction of response to antidepressant medication.
Journal ArticleDOI

Brain electrical source differences between depressed subjects and healthy controls.

TL;DR: LORETA detects differences in brain activity between MDD subjects and healthy controls that are consistent with previous findings using other imaging modalities, but results are not always consistent across studies, nor with findings from other Imaging modalities.
Journal ArticleDOI

A new paradigm for the prediction of antidepressant treatment response.

TL;DR: Data presented here suggest that early changes in symptoms, quantitative electroencephalography, and gene expression could be used to construct effective REs, a new paradigm in which medication treatment trials that are likely to be ineffective could be stopped within 1 to 2 weeks and other medication morelikely to be effective could be started.
Journal ArticleDOI

Functional neuroanatomy of visual masking deficits in schizophrenia

TL;DR: The current results indicate that patients fail to activate LO to the same extent as controls during visual processing regardless of stimulus visibility, suggesting a neural basis for the visual masking deficit, and possibly other visual integration deficits, in schizophrenia.